ABBVIE Stock- IN BRIEF: Judge pares down claims in Allegan breast implant MDL
A federal judge on Friday ruled that a multidistrict litigation over the alleged cancer risk of Allergan’s recalled Biocell textured breast implants can go forward, but scaled back its claims.
U.S. District Judge Brian Martinotti in New Jersey found some of the claims were preempted by federal law, partly granting a motion by Allergan to dismiss. Allergan was bought last year by Abbvie Inc, whose Allergan Aesthetics division now handles the Biocell recall.
To read the full story on Westlaw Today, click here: bit.ly/3vHSfCX